EXEL
NASDAQ HealthcareExelixis, Inc. - Common Stock
Biotechnology
📊 Market Data
| Price | $41.17 |
|---|---|
| Volume | 2,213,030 |
| Market Cap | 11.04B |
| Beta | 0.410 |
| RSI (14-Day) | 38.3 |
| 200-Day MA | $41.61 |
| 50-Day MA | $43.36 |
| 52-Week High | $49.62 |
| 52-Week Low | $32.38 |
| P/E Ratio | 14.81 |
| Forward P/E | 10.48 |
| Price / Book | 5.00 |
🎯 Investment Strategy Scores
How EXEL scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
46/100
High dividend yield + low volatility
🚀 Moon Shot
25/100
High growth potential (high beta + oversold)
🔪 Falling Knife
48/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
50/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
75/100
Large-cap, institutional-quality stocks
Find EXEL in your text
Paste any text on the homepage — the tool will extract EXEL and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.